HomeSABSW • NASDAQ
add
SAB Biotherapeutics
Previous close
$0.044
Day range
$0.049 - $0.053
Year range
$0.012 - $0.19
Market cap
27.78M USD
Avg Volume
18.16K
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 263.14K | 207.70% |
Operating expense | 3.64M | 25.61% |
Net income | -7.34M | -6.61% |
Net profit margin | -2.79K | 65.35% |
Earnings per share | — | — |
EBITDA | -9.17M | -63.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 37.33M | 380.11% |
Total assets | 61.89M | 74.63% |
Total liabilities | 15.77M | 0.29% |
Total equity | 46.12M | — |
Shares outstanding | 9.23M | — |
Price to book | 0.01 | — |
Return on assets | -38.28% | — |
Return on capital | -46.48% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.34M | -6.61% |
Cash from operations | -7.72M | -57.53% |
Cash from investing | 11.22M | 49,556.96% |
Cash from financing | -321.04K | 11.75% |
Net change in cash | 3.21M | 160.70% |
Free cash flow | -4.64M | -10.93% |
About
Founded
2014
Headquarters
Website
Employees
57